UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
(Address of principal executive offices, including zip code)
(Registrant's telephone number, including area code)
Note Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange On which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 2.02 Results of Operations and Financial Condition
On April 27, 2023, CBIZ, Inc. (the "Company") issued a press release announcing its financial results for the three months ended March 31, 2023. A copy of the press release is furnished herewith as Exhibit 99.1. The exhibit contains, and may implicate, forward-looking statements regarding the Company and include cautionary statements identified important factors that could cause actual results to differ materially from those anticipated.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
99.1 Press Release of CBIZ, Inc. dated April 27, 2023, announcing its financial results for the three months ended March 31, 2023.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES:
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: April 28, 2023
CBIZ, Inc.
| By: | /s/ Ware H. Grove | |||||||
| Name: | Ware H. Grove | |||||||
| Title: | Chief Financial Officer | |||||||
Exhibit 99.1
 |  | ||||||||||||||||
| FOR IMMEDIATE RELEASE | CONTACT: | Ware Grove | |||||||||||||||
| Chief Financial Officer | |||||||||||||||||
| -or- | |||||||||||||||||
| Lori Novickis | |||||||||||||||||
| Director, Corporate Relations | |||||||||||||||||
| CBIZ, Inc. | |||||||||||||||||
| Cleveland, Ohio | |||||||||||||||||
| (216) 447-9000 | |||||||||||||||||
CBIZ REPORTS FIRST-QUARTER 2023 RESULTS
FIRST-QUARTER HIGHLIGHTS:
•TOTAL REVENUE UP 16.1%; SAME-UNIT REVENUE UP 10.0%
•GAAP EPS UP 30.9%; ADJUSTED EPS UP 23.7%
•NET INCOME UP 25.9%; ADJUSTED EBITDA UP 22.0%
CLEVELAND (April 27, 2023) – CBIZ, Inc., (NYSE: CBZ) (“CBIZ” or the “Company”), a leading provider of financial, insurance and advisory services, today announced results for the first quarter ended March 31, 2023.
For the 2023 first quarter, CBIZ recorded revenue of $454.6 million, an increase of $62.9 million, or 16.1%, compared with $391.7 million reported for the same period in 2022. Acquired operations, net of divestitures, contributed $23.6 million, or 6.1%, to revenue growth. Same-unit revenue increased by $39.3 million, or 10.0%, for the quarter, compared with the same period a year ago. Net income was $73.2 million, or $1.44 per diluted share, compared with $58.1 million, or $1.10 per diluted share, for the same period a year ago.
Excluding non-recurring transaction and first-year integration expenses related to the acquisition of Marks Paneth in January 2022, and expenses related to the acquisition of Somerset in February 2023, Adjusted net income was $74.3 million in the first quarter of 2023 compared with Adjusted net income of $62.6 million for the same period a year ago. Adjusted earnings per share was $1.46, an increase of 23.7% compared with Adjusted earnings per share of $1.18 for the same period a year ago. Adjusted EBITDA for the first quarter was $113.3 million, up 22.0% compared with $92.9 million for the same period in 2022.
Schedules reconciling Adjusted net income, Adjusted earnings per share and Adjusted EBITDA to the most directly comparable GAAP measures can be found in the tables included in this release.
Page 1 of 10
NYSE: CBZ ● www.cbiz.com ● Twitter @cbz
During the three months ended March 31, 2023, the Company repurchased approximately 0.4 million shares of its common stock on the open market. Between April 1, 2023 and April 26, 2023, the Company repurchased an additional 0.2 million shares. The balance outstanding on the Company’s unsecured credit facility on March 31, 2023, was $403.7 million with $190.0 million of unused borrowing capacity.
Jerry Grisko, CBIZ President and Chief Executive Officer, said, “With same unit revenue up 10.0% and total revenue up 16.1%, we are pleased that our strong performance in 2022 has continued into the first quarter of 2023. With this encouraging start to our year, we would expect our full-year results to come in at the high-end of the guidance that we provided in February of this year.”
“We are also pleased to bring another outstanding accounting firm to our CBIZ team with the acquisition of the non-attest assets of Somerset CPAs and Advisors which closed effective February 1 of this year. Although they have only been with us for a short time, Somerset is performing in line with expectations and was a meaningful contributor to strong first quarter results. We continue to have a healthy pipeline of acquisition candidates and access to sufficient funds to pursue those opportunities.” Grisko concluded.
2023 Outlook
•The Company expects revenue to grow within a range of 8% to 10% over the prior year.
•The Company expects an effective tax rate of approximately 28%. The increased rate, up from 25.5% in 2022, will impact diluted earnings per share by approximately $0.08.
•The Company expects a weighted average fully diluted share count of approximately 50.5 to 51.0 million shares.
•The Company expects GAAP fully diluted earnings per share to grow within a range of 15% to 17%, to $2.31 to $2.36 per share over the $2.01 per share reported for 2022.
•The Company expects Adjusted fully diluted earnings per share to grow within a range of 11% to 13%, to $2.36 to $2.41 per share over the Adjusted earnings per share of $2.13 per share reported for 2022.
Conference Call
CBIZ will host a conference call at 11:00 a.m. (ET) today to discuss its results. The call will be webcast and an archived replay will be available at https://cbiz.gcs-web.com/investor-overview. Participants may register at https://dpregister.com/sreg/10177806/f911fa5dfc.
About CBIZ
CBIZ is a leading provider of financial, insurance and advisory services to businesses throughout the United States. Financial services include accounting, tax, government health care consulting, transaction advisory, risk advisory, and valuation services. Insurance services include employee benefits consulting, retirement plan consulting, property and casualty insurance, payroll, and human capital consulting. With more than 120 offices in 33 states, CBIZ is one of the largest accounting and insurance brokerage providers in the U.S. For more information, visit www.cbiz.com.
Forward-Looking Statements
Forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to certain risks and
Page 2 of 10
NYSE: CBZ ● www.cbiz.com ● Twitter @cbz
uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include, but are not limited to, the risk that the anticipated benefits and perceived advantages of an acquisition may not be achieved; the impact of COVID-19 or governmental rules related to public health issues on the Company’s business, operations and clients; the Company’s ability to adequately manage and sustain its growth; the Company’s dependence on the trend of outsourcing business services; the Company’s dependence on the services of its CEO, other key employees, producers and service personnel; the effects of any potential cyber-attacks; competitive pricing pressures; general business and economic conditions; and changes in governmental laws or regulation affecting the Company’s clients, business, business services operations, or business models. A more detailed description of such risks and uncertainties may be found in the Company’s filings with the Securities and Exchange Commission at www.sec.gov.
Page 3 of 10
NYSE: CBZ ● www.cbiz.com ● Twitter @cbz
CBIZ, INC.
FINANCIAL HIGHLIGHTS (UNAUDITED)
THREE MONTHS ENDED MARCH 31, 2023 AND 2022
(In thousands, except percentages and per share data)
| Three Months Ended March 31, | ||||||||||||||||||||||||||
| 2023 | % | 2022 | % | |||||||||||||||||||||||
| Revenue | $ | 454,606 | 100.0 | % | $ | 391,722 | 100.0 | % | ||||||||||||||||||
Operating expenses (1) | 341,011 | 75.0 | 290,299 | 74.1 | ||||||||||||||||||||||
| Gross margin | 113,595 | 25.0 | 101,423 | 25.9 | ||||||||||||||||||||||
Corporate general and administrative expenses (1) | 15,598 | 3.4 | 16,309 | 4.2 | ||||||||||||||||||||||
| Operating income | 97,997 | 21.6 | 85,114 | 21.7 | ||||||||||||||||||||||
| Other income (expense): | ||||||||||||||||||||||||||
| Interest expense | (3,641) | (0.8) | (1,259) | (0.3) | ||||||||||||||||||||||
| Gain on sale of operations, net | 99 | — | — | — | ||||||||||||||||||||||
Other income (expense), net (1) (2) | 5,112 | 1.1 | (6,407) | (1.6) | ||||||||||||||||||||||
| Total other income (expense), net | 1,570 | 0.3 | (7,666) | (1.9) | ||||||||||||||||||||||
| Income before income tax expense | 99,567 | 21.9 | 77,448 | 19.8 | ||||||||||||||||||||||
| Income tax expense | 26,407 | 19,321 | ||||||||||||||||||||||||
| Net income | $ | 73,160 | 16.1 | % | $ | 58,127 | 14.8 | % | ||||||||||||||||||
| Diluted earnings per share | $ | 1.44 | $ | 1.10 | ||||||||||||||||||||||
| Diluted weighted average common shares outstanding | 50,762 | 52,955 | ||||||||||||||||||||||||
| Other data: | ||||||||||||||||||||||||||
Adjusted EBITDA (3) | $ | 113,348 | $ | 92,892 | ||||||||||||||||||||||
Adjusted EPS (3) | $ | 1.46 | $ | 1.18 | ||||||||||||||||||||||
(1)CBIZ sponsors a deferred compensation plan, under which a CBIZ employee's compensation deferral is held in a rabbi trust and invested accordingly as directed by the employee. Income and expenses related to the deferred compensation plan are included in "Operating expenses" and "Corporate general and administrative expenses," and are directly offset by deferred compensation gains or losses in "Other income (expense), net." The deferred compensation plan has no impact on "Income before income tax expense."
Income and expenses related to the deferred compensation plan for the three months ended March 31, 2023, and 2022 are as follows (in thousands):
| Three Months Ended March 31, | ||||||||||||||||||||||||||
| 2023 | % of Revenue | 2022 | % of Revenue | |||||||||||||||||||||||
| Operating expenses (income) | $ | 4,760 | 1.0 | % | $ | (5,667) | (1.4) | % | ||||||||||||||||||
| Corporate general and administrative expense (income) | 642 | 0.1 | % | (811) | (0.2) | % | ||||||||||||||||||||
| Other income (expense), net | 5,402 | 1.2 | % | (6,478) | (1.7) | % | ||||||||||||||||||||
Page 4 of 10
NYSE: CBZ ● www.cbiz.com ● Twitter @cbz
Excluding the impact of the above-mentioned income and expenses related to the deferred compensation plan, the operating results for the three months ended March 31, 2023, and 2022 are as follows (in thousands):
| Three Months Ended March 31, | |||||||||||||||||||||||||||||||||||||||||||||||
| 2023 | 2022 | ||||||||||||||||||||||||||||||||||||||||||||||
| As Reported | Deferred Compensation Plan | Adjusted | % of Revenue | As Reported | Deferred Compensation Plan | Adjusted | % of Revenue | ||||||||||||||||||||||||||||||||||||||||
| Gross margin | $ | 113,595 | $ | 4,760 | $ | 118,355 | 26.0 | % | $ | 101,423 | $ | (5,667) | $ | 95,756 | 24.4 | % | |||||||||||||||||||||||||||||||
| Operating income | 97,997 | 5,402 | 103,399 | 22.7 | % | 85,114 | (6,478) | 78,636 | 20.1 | % | |||||||||||||||||||||||||||||||||||||
| Other income (expense), net | 5,112 | (5,402) | (290) | (0.1) | % | (6,407) | 6,478 | 71 | — | % | |||||||||||||||||||||||||||||||||||||
| Income before income tax expense | 99,567 | — | 99,567 | 21.9 | % | 77,448 | — | 77,448 | 19.8 | % | |||||||||||||||||||||||||||||||||||||
(2)Included in "Other income (expense), net" for the three months ended March 31, 2023 and 2022, is expense of $0.6 million and $0.6 million, respectively, related to net changes in the fair value of contingent consideration related to CBIZ's prior acquisitions.
(3)Refer to the financial highlights tables for a reconciliation of Non-GAAP financial measures to the most directly comparable GAAP financial measure, and for additional information as to the usefulness of the Non-GAAP financial measures to shareholders and investors.
Page 5 of 10
NYSE: CBZ ● www.cbiz.com ● Twitter @cbz
CBIZ, INC.
FINANCIAL HIGHLIGHTS (UNAUDITED)
(In thousands)
SELECT SEGMENT DATA
| Three Months Ended March 31, | ||||||||||||||
| 2023 | 2022 | |||||||||||||
| Revenue | ||||||||||||||
| Financial Services | $ | 343,086 | $ | 288,746 | ||||||||||
| Benefits and Insurance Services | 100,054 | 92,486 | ||||||||||||
| National Practices | 11,466 | 10,490 | ||||||||||||
| Total | $ | 454,606 | $ | 391,722 | ||||||||||
| Gross Margin | ||||||||||||||
| Financial Services | $ | 98,643 | $ | 78,946 | ||||||||||
| Benefits and Insurance Services | 23,131 | 19,829 | ||||||||||||
| National Practices | 883 | 914 | ||||||||||||
Operating expenses - unallocated (1): | ||||||||||||||
| Other expense | (4,302) | (3,933) | ||||||||||||
| Deferred compensation | (4,760) | 5,667 | ||||||||||||
| Total | $ | 113,595 | $ | 101,423 | ||||||||||
(1)Represents operating expenses not directly allocated to individual businesses, including stock-based compensation, consolidation and integration charges, and certain advertising expenses. "Operating expenses - unallocated" also includes gains or losses attributable to the assets held in a rabbi trust associated with the Company's deferred compensation plan. These gains or losses do not impact "Income before income tax expense" as they are directly offset by the same adjustment to "Other income (expense), net" in the Consolidated Statements of Comprehensive Income. Net gains/losses recognized from adjustments to the fair value of the assets held in the rabbi trust are recorded as compensation expense (income) in "Operating expenses" and “Corporate, general and administrative expenses,” and offset in "Other income (expense), net."
Page 6 of 10
NYSE: CBZ ● www.cbiz.com ● Twitter @cbz
CBIZ, INC.
SELECT CASH FLOW DATA (UNAUDITED)
(In thousands)
| Three Months Ended March 31, | ||||||||||||||
| 2023 | 2022 | |||||||||||||
| Net income | $ | 73,160 | $ | 58,127 | ||||||||||
| Adjustments to reconcile net income to net cash used in operating activities: | ||||||||||||||
| Depreciation and amortization expense | 8,625 | 8,173 | ||||||||||||
| Gain on sale of operations, net | (99) | — | ||||||||||||
| Bad debt expense, net of recoveries | 461 | 549 | ||||||||||||
| Adjustments to contingent earnout liability, net | 630 | 642 | ||||||||||||
| Stock-based compensation expense | 3,831 | 3,689 | ||||||||||||
| Other noncash adjustments | 2,749 | 2,992 | ||||||||||||
| Net income, after adjustments to reconcile net income to net cash provided by operating activities | 89,357 | 74,172 | ||||||||||||
| Changes in assets and liabilities, net of acquisitions and divestitures | (133,868) | (125,062) | ||||||||||||
| Net cash used in operating activities | (44,511) | (50,890) | ||||||||||||
| Net cash used in investing activities | (45,896) | (81,531) | ||||||||||||
| Net cash provided by financing activities | 61,778 | 170,446 | ||||||||||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | (28,629) | 38,025 | ||||||||||||
| Cash, cash equivalents and restricted cash at beginning of year | $ | 160,145 | $ | 150,474 | ||||||||||
| Cash, cash equivalents and restricted cash at end of period | $ | 131,516 | $ | 188,499 | ||||||||||
| Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet: | ||||||||||||||
| Cash and cash equivalents | $ | 2,265 | $ | 558 | ||||||||||
| Restricted cash | 25,109 | 33,394 | ||||||||||||
| Cash equivalents included in funds held for clients | 104,142 | 154,547 | ||||||||||||
| Total cash, cash equivalents and restricted cash | $ | 131,516 | $ | 188,499 | ||||||||||
Page 7 of 10
NYSE: CBZ ● www.cbiz.com ● Twitter @cbz
CBIZ, INC.
SELECT FINANCIAL DATA AND RATIOS (UNAUDITED)
(In thousands)
| March 31, 2023 | December 31, 2022 | |||||||||||||
| Cash and cash equivalents | 2,265 | 4,697 | ||||||||||||
| Restricted cash | 25,109 | 28,487 | ||||||||||||
| Accounts receivable, net | 442,781 | 334,498 | ||||||||||||
| Current assets before funds held for clients | 501,617 | 397,113 | ||||||||||||
| Funds held for clients | 148,240 | 171,313 | ||||||||||||
| Goodwill and other intangible assets, net | 1,005,873 | 951,702 | ||||||||||||
| Total assets | 2,038,196 | 1,879,124 | ||||||||||||
| Current liabilities before client fund obligations | 310,942 | 338,940 | ||||||||||||
| Client fund obligations | 150,216 | 173,467 | ||||||||||||
| Total long-term debt, net | 401,772 | 263,654 | ||||||||||||
| Total liabilities | 1,266,266 | 1,165,672 | ||||||||||||
| Treasury stock | (853,793) | (824,778) | ||||||||||||
| Total stockholders' equity | 771,930 | 713,452 | ||||||||||||
| Debt to equity | 52.0 | % | 37.0 | % | ||||||||||
Days sales outstanding (DSO) (1) | 94 | 74 | ||||||||||||
| Shares outstanding | 50,312 | 50,180 | ||||||||||||
| Basic weighted average common shares outstanding | 50,367 | 51,502 | ||||||||||||
| Diluted weighted average common shares outstanding | 50,762 | 52,388 | ||||||||||||
(1)DSO is provided for continuing operations and represents accounts receivable, net, at the end of the period, divided by trailing twelve month daily revenue. The Company has included DSO data because such data is commonly used as a performance measure by analysts and investors and as a measure of the Company's ability to collect on receivables in a timely manner. DSO should not be regarded as an alternative or replacement to any measurement of performance under GAAP. DSO on March 31, 2022 was 94.
Page 8 of 10
NYSE: CBZ ● www.cbiz.com ● Twitter @cbz
CBIZ, INC.
GAAP RECONCILIATION
Net Income and Diluted Earnings Per Share (“EPS”) to Adjusted Net Income, EPS and EBITDA(1)
(In thousands, except per share data)
| Three Months Ended March 31, 2023 | Three Months Ended March 31, 2022 | ||||||||||||||||||||||
| Amounts | EPS | Amounts | EPS | ||||||||||||||||||||
| Net income | $ | 73,160 | $ | 1.44 | $ | 58,127 | $ | 1.10 | |||||||||||||||
| Adjustments: | |||||||||||||||||||||||
Transaction costs related to acquisitions (2) | 611 | 0.01 | 1,329 | 0.03 | |||||||||||||||||||
Integration & retention costs related to acquisitions (2) | 1,003 | 0.02 | 4,684 | 0.09 | |||||||||||||||||||
| Income tax effect related to adjustments | (428) | (0.01) | (1,500) | (0.04) | |||||||||||||||||||
| Adjusted net income | $ | 74,346 | $ | 1.46 | $ | 62,640 | $ | 1.18 | |||||||||||||||
| Interest expense | $ | 3,641 | $ | 1,259 | |||||||||||||||||||
| Income tax expense | 26,407 | 19,321 | |||||||||||||||||||||
| Gain on sale of operations, net | (99) | — | |||||||||||||||||||||
| Tax effect related to the adjustments above | 428 | 1,500 | |||||||||||||||||||||
| Depreciation | 2,975 | 2,779 | |||||||||||||||||||||
| Amortization | 5,650 | 5,394 | |||||||||||||||||||||
| Adjusted EBITDA | $ | 113,348 | $ | 92,893 | |||||||||||||||||||
(1)CBIZ reports its financial results in accordance with GAAP. This table reconciles Adjusted net income, Adjusted EPS and Adjusted EBITDA to the most directly comparable GAAP financial measures, “Net income” and "Diluted earnings per share." Adjusted net income, Adjusted EPS and Adjusted EBITDA are not defined by GAAP and should not be regarded as an alternative or replacement to any measurement of performance under GAAP. Adjusted net income, Adjusted EPS and Adjusted EBITDA, which excludes significant non-operating related gains and losses, are used by the Company for its shareholders and debt holders as a performance measure to evaluate, assess and benchmark the Company's operational results.
(2)These costs include, but are not limited to, certain consulting, technology, personnel, as well as other first year operating and general administrative costs that are non-recurring in nature. Amounts reported in 2023 related to the costs incurred related to the Somerset acquisition and those reported in 2022 related to the Marks Paneth acquisition.
Page 9 of 10
NYSE: CBZ ● www.cbiz.com ● Twitter @cbz
CBIZ, INC.
GAAP RECONCILIATION
Full Year 2023 Net Income and Diluted Earnings Per Share (“EPS”) to
Adjusted Net Income, EPS and EBITDA Guidance
(Amount in millions, except per share data)
| Full Year 2023 Guidance | |||||||||||||||||||||||
| Low | High | ||||||||||||||||||||||
| Amount | Per Share | Amount | Per Share | ||||||||||||||||||||
| Net income | $ | 121.1 | $ | 2.31 | $ | 123.2 | $ | 2.36 | |||||||||||||||
Transaction and integration costs related to Somerset (1) | 3.6 | 0.07 | 3.6 | 0.07 | |||||||||||||||||||
| Income tax effect related to adjustments | (1.0) | $ | (0.02) | (1.0) | $ | (0.02) | |||||||||||||||||
| Adjusted net income | $ | 123.7 | $ | 2.36 | $ | 125.8 | $ | 2.41 | |||||||||||||||
| Interest expense | $ | 20.8 | $ | 20.8 | |||||||||||||||||||
| Income tax expense | 47.2 | 47.2 | |||||||||||||||||||||
| Tax effect related to the adjustments above | 1.0 | 1.0 | |||||||||||||||||||||
| Depreciation and amortization | 35.9 | 35.9 | |||||||||||||||||||||
| Adjusted EBITDA | $ | 228.6 | $ | 230.7 | |||||||||||||||||||
| GAAP diluted EPS for 2022 | $ | 2.01 | $ | 2.01 | |||||||||||||||||||
Adjusted diluted EPS for 2022 (2) | $ | 2.13 | $ | 2.13 | |||||||||||||||||||
| GAAP diluted EPS range | 15 | % | 17 | % | |||||||||||||||||||
| Adjusted diluted EPS range | 11 | % | 13 | % | |||||||||||||||||||
| GAAP Net income for 2022 | $ | 105.4 | $ | 105.4 | |||||||||||||||||||
| GAAP Net income range | 15 | % | 17 | % | |||||||||||||||||||
(1)Includes estimated integration costs related to the Somerset acquisition. Such costs include, but are not limited to, certain consulting, technology, personnel, as well as other first year operating and general administrative costs that are non-recurring in nature.
(2)A reconciliation between net income and adjusted net income and a reconciliation between GAAP diluted EPS and Adjusted diluted EPS for fiscal year ended December 31, 2022 are presented as follows:
| Year Ended December 31, 2022 | |||||||||||
| In millions | EPS | ||||||||||
| Net income | $ | 105.4 | $ | 2.01 | |||||||
| Adjustments: | |||||||||||
| Gain on sale of assets, net | (2.4) | (0.05) | |||||||||
| Transaction costs related to Marks Paneth | 1.3 | 0.03 | |||||||||
| Integration and retention costs related to Marks Paneth | 9.2 | 0.18 | |||||||||
| Income tax effect related to adjustments | (2.1) | (0.04) | |||||||||
| Adjusted net income | $ | 111.4 | $ | 2.13 | |||||||
Page 10 of 10
NYSE: CBZ ● www.cbiz.com ● Twitter @cbz